Medicare Enrolled

Dr. Jeffrey Ferraro, MD

Psychiatry · Tallahassee, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2606 CENTENNIAL PL, Tallahassee, FL 32308
8502050189
In practice since 2006 (19 years)
NPI: 1093805186 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ferraro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ferraro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ferraro

Dr. Jeffrey Ferraro is a psychiatry in Tallahassee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ferraro performed 36 Medicare services across 13 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ferraro received a total of $4,432 from 33 pharmaceutical and/or device companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ferraro is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 36 Medicare services$ $4,432 industry payments

Medicare Practice Summary

Medicare Utilization ↗
36
Medicare services
Bottom 7% in FL for psychiatry
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
13
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity36$83$168
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,432
Total received (2018-2024)
Avg $633/year across 7 years
Top 16% in FL for psychiatry
33
Companies
280
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,432 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$830
2023
$321
2022
$462
2021
$396
2020
$119
2019
$1,125
2018
$1,180

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$569
Lundbeck LLC
$440
Takeda Pharmaceuticals U.S.A., Inc.
$435
Otsuka America Pharmaceutical, Inc.
$357
Allergan Inc.
$292
Teva Pharmaceuticals USA, Inc.
$275
Vanda Pharmaceuticals Inc.
$263
Shire North American Group Inc
$193
Almatica Pharma LLC
$144
AbbVie Inc.
$143
ITI, Inc.
$142
Neurocrine Biosciences, Inc.
$136
Sunovion Pharmaceuticals Inc.
$125
Janssen Pharmaceuticals, Inc
$114
Tempus AI, Inc
$97
Axsome Therapeutics, Inc.
$67
Neos Therapeutics, LP
$65
Eisai Inc.
$64
JAZZ PHARMACEUTICALS INC.
$62
EISAI INC.
$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$54
Merck Sharp & Dohme Corporation
$46
Corium, LLC
$45
Jazz Pharmaceuticals Inc.
$42
Bausch Health US, LLC
$40
Avanir Pharmaceuticals, Inc.
$38
Pernix Therapeutics Holdings, Inc.
$28
Ironshore Pharmaceuticals Inc.
$24
Allergan, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$19
OWP Pharmaceuticals, Inc.
$14
Neuronetics, Inc.
$12
Rhodes Pharmaceuticals L.P.
$12
Top 3 companies account for 32.6% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · APLENZIN · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · CITALOPRAM · Dayvigo · FANAPT · Fanapt · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · LATUDA · LOREEV XR · Lamotrigine Starter Kit · NEUROSTAR TMS THERAPY · NUEDEXTA · QUVIVIQ · REXULTI · SERTRALINE HCL · SILENOR · SPRAVATO · SUNOSI · TRINTELLIX · Trintellix · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $12,311 per 100 Medicare services performed
Looking for a psychiatry in Tallahassee?
Compare psychiatrys in the Tallahassee area by procedure volume, costs, and industry payment transparency.
Browse psychiatrys nearby

Geographic Context

Psychiatrys within 10 mi
85
Per 100K population
28.8
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ferraro is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 16%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ferraro experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Ferraro performed 36 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ferraro receive payments from pharmaceutical companies?
Yes. Dr. Ferraro received a total of $4,432 from 33 companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ferraro's costs compare to other psychiatrys in Tallahassee?
Dr. Ferraro's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ferraro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →